Allergan plcAGN and Hungary based partner Gedeon Richter Plc. announced that the FDA has approved their Vraylar (cariprazine) capsules for the acute treatment of manic or mixed episodes associated with bipolar I disorder and for the treatment of schizophrenia
Allergan/Gedeon's Vraylar Gets FDA Nod for Mental Disorders
